Maraviroc
Tocris Bioscience, part of Bio-Techne | Catalog # 3756
Selective CCR5 antagonist
Key Product Details
Description
Selective CCR5 antagonist
Alternative Names
UK-427857
Product Description
Maraviroc is a selective CCR5 antagonist; displays potent anti-HIV-1 activity. Prevents the interaction of HIV-1 gp120 and CCR5 (IC50 = 6.4 nM), inhibiting HIV-1 entry. Exhibits antinociceptive effects in a rat model of neuropathic pain. Also inhibits CCL3 (MIP-1α) binding to CCR5. Orally bioavailable.Licensing Information
Sold for research purposes under agreement from Viiv.Product Specifications
Molecular Weight
513.67
Formula
C29H41F2N5O
Storage
Store at +4°C
Purity
≥98% (HPLC)
Chemical Name
4,4-Difluoro-N-{(1S)-3-[3-(3-isopropyl- 5-methyl-4H-1,2,4-triazol-4-yl)- 8-azabicyclo[3.2.1]oct-8-yl]-1- phenylpropyl}cyclohexanecarboxamide
CAS Number
376348-65-1
PubChem ID
483407
InChI Key
GSNHKUDZZFZSJB-ILVMPNSOSA-N
SMILES
O=C(C4CCC(F)(F)CC4)N[C@@H](CCN2C3CCC2CC(N5C(C)=NN=C5C(C)C)C3)C1=CC=CC=C1
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 38.53 | 75 | |
| Ethanol | 51.37 | 100 |
Preparing Stock Solutions
for Maraviroc
The following data is based on the product molecular weight 513.67
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.95 mL | 9.73 mL | 19.47 mL |
| 5 mM | 0.39 mL | 1.95 mL | 3.89 mL |
| 10 mM | 0.19 mL | 0.97 mL | 1.95 mL |
| 50 mM | 0.04 mL | 0.19 mL | 0.39 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Piotrowska Maraviroc reduces neuropathic pain through polarization of microglia and astroglia - Evidence from in vivo and in vitro studies. Neuropharmacology 2016 PMID: 27117708
- Garcia-Perez New insights into the mechanisms whereby low molecular weight CCR5 ligands inhibit HIV-1 infection. J.Biol.Chem. 2011 PMID: 21118814
- Kuritzkes Fresh from the pipeline - mara. Nat.Rev.Drug Discov.
- Dorr Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity. Antimicrob.Agents Chemother. 2005 PMID: 16251317
Product Specific Notices for Maraviroc
For research use only
Loading...
Loading...
Loading...